Human Papillomavirus (HPV) Infection Completed Phase 3 Trials for Clostridium tetani toxoid antigen (formaldehyde inactivated) (DB10583)

Back to Human Papillomavirus (HPV) Infection

Also known as: Human Papillomavirus Infections / Human Papilloma Virus Infection / Human Papillomavirus Infection / Human Papillomavirus (HPV) Infections / HPV infection / Human papillomavirus infection (disorder) / Papillomavirus Infections / Disease caused by Papillomavirus (disorder) / Papilloma viral infection / Papilloma viral infection NOS / Papilloma viral infections

Indication	Status	Phase
DBCOND0032819 (Human Papillomavirus (HPV) Infection)	Completed	3

clinicaltrials.gov Identifier	Title	Purpose	Drugs
NCT00988884	A Study of V503 Given Concomitantly With Menactra™ and Adacel™ in 11 to 15 Year Olds (V503-005)	Prevention	Bordetella pertussis filamentous hemagglutinin antigen (formaldehyde inactivated) (DB10788) Bordetella pertussis fimbriae 2/3 antigen (DB10790) Bordetella pertussis pertactin antigen (DB10789) Bordetella pertussis toxoid antigen (formaldehyde, glutaraldehyde inactivated) (DB10991) Clostridium tetani toxoid antigen (formaldehyde inactivated) (DB10583) Corynebacterium diphtheriae toxoid antigen (formaldehyde inactivated) (DB10584) Neisseria meningitidis group a capsular polysaccharide diphtheria toxoid conjugate antigen (DB10798) Neisseria meningitidis group c capsular polysaccharide diphtheria toxoid conjugate antigen (DB10799) Neisseria meningitidis group w-135 capsular polysaccharide diphtheria toxoid conjugate antigen (DB10801) Neisseria meningitidis group y capsular polysaccharide diphtheria toxoid conjugate antigen (DB10800)